Rankings
▼
Calendar
VIR Q2 2025 Earnings — Vir Biotechnology, Inc. Revenue & Financial Results | Market Cap Arena
VIR
Vir Biotechnology, Inc.
$1B
Q2 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$1M
-60.5% YoY
Gross Profit
-$96M
-7932.9% margin
Operating Income
-$118M
-9754.3% margin
Net Income
-$111M
-9139.9% margin
EPS (Diluted)
$-0.80
QoQ Revenue Growth
-60.0%
Cash Flow
Operating Cash Flow
-$120M
Free Cash Flow
-$123M
Stock-Based Comp.
$12M
Balance Sheet
Total Assets
$1.2B
Total Liabilities
$245M
Stockholders' Equity
$947M
Cash & Equivalents
$211M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$1M
$3M
-60.5%
Gross Profit
-$96M
-$102M
+5.7%
Operating Income
-$118M
-$159M
+25.4%
Net Income
-$111M
-$138M
+19.8%
Revenue Segments
Contract Revenue
$2M
89%
Grant
$183,000
11%
Geographic Segments
Non-US
$2M
89%
UNITED STATES
$183,000
11%
← FY 2025
All Quarters
Q3 2025 →